Cargando…

Changes in Hematologic Parameters during Treatment with Medroxyprogesterone Acetate for Breast Cancer

To elucidate the etiology of the thrombogenic effects of high‐dose medroxyprogesterone acetate (MPA) in the treatment of breast cancer, hematologic parameters were sequentially assessed in 12 patients receiving MPA 800 mg p.o. daily for 6 months as adjuvant hormone therapy after mastectomy. The resu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamamoto, Hitoshi, Noguchi, Shinzaburo, Miyauchi, Keisuke, Inaji, Hideo, Imaoka, Shingi, Koyama, Hiroki, Iwanaga, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1991
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918452/ https://www.ncbi.nlm.nih.gov/pubmed/1828463 http://dx.doi.org/10.1111/j.1349-7006.1991.tb01865.x

Ejemplares similares

Influence of Tamoxifen‐Medroxyprogesterone Sequential Therapy on Estrogen and Progesterone Receptor Contents of Breast Cancer
por: Noguchi, Shinzaburo, et al.
Publicado: (1989)

Inhibitory Effect of a Somatostatin Analogue (SMS 201–995) on the Growth of Androgen‐dependent Mouse Mammary Tumor (Shionogi Carcinoma 115)
por: Noguchi, Shinzaburo, et al.
Publicado: (1993)

Prognostic Significance of Occult Bone Marrow Micrometastases of Breast Cancer Detected by Quantitative Polymerase Chain Reaction for Cytokeratin 19 mRNA
por: Ikeda, Noriko, et al.
Publicado: (2000)

Detection of Gastric Cancer Micrometastases in Lymph Nodes by Amplification of Keratin 19 mRNA with Reverse Transcriptase‐Polymerase Chain Reaction
por: Noguchi, Sbinzaburo, et al.
Publicado: (1996)

Hypercalcemia after the Discontinuation of Medroxyprogesterone Acetate
por: Yuasa-Shibasaki, Erina, et al.
Publicado: (2017)

Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial()()
por: Nanda, Kavita, et al.
Publicado: (2016)

In vitro Invasion of Endothelial Cell Monolayer by Rat Ascites Hepatoma Cells
por: Ohigashi, Hiroaki, et al.
Publicado: (1989)

Medroxyprogesterone Acetate (Provera) in the Treatment of Metastatic Renal Cancer*
por: Bloom, H. J. G.
Publicado: (1971)

Inhibitory Effects of Medroxyprogesterone Acetate on Mouse Endometrial Carcinogenesis
por: Niwa, Kenji, et al.
Publicado: (1995)

Prostacyclin and thromboxane in breast cancer: relationship between steroid receptor status and medroxyprogesterone acetate.
por: Aitokallio-Tallberg, A., et al.
Publicado: (1985)

An evaluation of high-dose medroxyprogesterone acetate (MPA) therapy in women with advanced breast cancer.
por: Johnson, J. R., et al.
Publicado: (1984)

Effect of medroxyprogesterone acetate on the response of the rat mammary gland to carcinogenesis.
por: Russo, I. H., et al.
Publicado: (1989)

Incidence of Galactorrhea in Young Women Using Depot-Medroxyprogesterone Acetate
por: Omar, Hatim A., et al.
Publicado: (2006)

The effect of depot medroxyprogesterone acetate on tenofovir alafenamide in rhesus macaques
por: Daly, Michele B., et al.
Publicado: (2020)

Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate
por: Taylor, Douglas J., et al.
Publicado: (2022)

Depot Medroxyprogesterone Acetate Use and the Development and Progression of Uterine Leiomyoma
por: Harmon, Quaker E., et al.
Publicado: (2022)

The pharmacokinetics of medroxyprogesterone acetate following two different loading dose schedules in advanced carcinoma of the breast.
por: Canney, P. A., et al.
Publicado: (1988)

Comparative actions of progesterone, medroxyprogesterone acetate, drospirenone and nestorone on breast cancer cell migration and invasion
por: Fu, Xiao-Dong, et al.
Publicado: (2008)

The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells
por: Ghatge, Radhika P, et al.
Publicado: (2005)

Effects of estradiol and medroxyprogesterone acetate on morphology, proliferation and apoptosis of human breast tissue in organ cultures
por: Eigėlienė, Natalija, et al.
Publicado: (2006)

Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery
por: Lam, Clarissa, et al.
Publicado: (2016)

Preferences for oral versus intravenous adjuvant chemotherapy among early breast cancer patients
por: Ishitobi, Makoto, et al.
Publicado: (2013)

Combined effect of navelbine with medroxyprogesterone acetate against human breast carcinoma MCF-7 cells in vitro.
por: Sugiyama, K., et al.
Publicado: (1998)

Modulation of Adriamycin Resistance in Human Breast Carcinoma MCF‐7 Cells in vitro and in vivo by Medroxyprogesterone Acetate
por: Ishida, Hiroyuki, et al.
Publicado: (1994)

Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma.
por: Becher, R., et al.
Publicado: (1989)

Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia
por: Khanim, Farhat L., et al.
Publicado: (2009)

Comparison of Sexual Dysfunction in Women Using Depo-Medroxyprogesterone Acetate (DMPA) and Cyclofem
por: Ozgoli, Giti, et al.
Publicado: (2015)

Colorectal tumor prevention by the progestin medroxyprogesterone acetate is critically dependent on postmenopausal status
por: Meijer, Bartolomeus J., et al.
Publicado: (2018)

An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA)()()
por: Katz, Micah, et al.
Publicado: (2020)

The potential for intramuscular depot medroxyprogesterone acetate as a self-bridging emergency contraceptive()
por: Schickler, Robyn, et al.
Publicado: (2020)

Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630
por: Potkul, Ronald K, et al.
Publicado: (2016)

A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia.
por: Downer, S., et al.
Publicado: (1993)

Uterine leiomyoma and its association with menstrual pattern and history of depo-medroxyprogesterone acetate injections
por: Amanti, L, et al.
Publicado: (2011)

Effects of Long-term Use of Depo-medroxyprogesterone Acetate on Lipid Metabolism in Nepalese Women
por: Yadav, Binod Kumar, et al.
Publicado: (2011)

High-risk sexual behaviors while on depot medroxyprogesterone acetate as compared to oral contraception
por: Bartz, Deborah, et al.
Publicado: (2017)

Dietary intake and eating behavior in depot medroxyprogesterone acetate users: a systematic review
por: Silva, P., et al.
Publicado: (2018)

Depot Medroxyprogesterone Acetate Use and Blood Lead Levels in a Cohort of Young Women
por: Upson, Kristen, et al.
Publicado: (2020)

An updated review on the effects of depot medroxyprogesterone acetate on the mucosal biology of the female genital tract
por: Ayele, Hossaena, et al.
Publicado: (2021)

Multi-omics analysis of the cervical epithelial integrity of women using depot medroxyprogesterone acetate
por: Bradley, Frideborg, et al.
Publicado: (2022)

A Rare Case of Splenic Artery Thrombosis Provoked By Medroxyprogesterone Acetate Requiring Splenectomy
por: Haider, Asad A, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cbcub4pr9thlleloe2q5qpd07q